Mainz Biomed N.V (MYNZ) EPS (Weighted Average and Diluted): 2020-2024
Historic EPS (Weighted Average and Diluted) for Mainz Biomed N.V (MYNZ) over the last 5 years, with Dec 2024 value amounting to -$22.36.
- Mainz Biomed N.V's EPS (Weighted Average and Diluted) fell 2106.96% to -$12.76 in Q4 2023 from the same period last year, while for Dec 2023 it was -$64.76, marking a year-over-year decrease of 3374.46%. This contributed to the annual value of -$22.36 for FY2024, which is 65.47% up from last year.
- Latest data reveals that Mainz Biomed N.V reported EPS (Weighted Average and Diluted) of -$22.36 as of FY2024, which was up 65.47% from -$64.76 recorded in FY2023.
- Over the past 5 years, Mainz Biomed N.V's EPS (Weighted Average and Diluted) peaked at -$0.10 during FY2020, and registered a low of -$74.55 during FY2022.
- For the 3-year period, Mainz Biomed N.V's EPS (Weighted Average and Diluted) averaged around -$53.89, with its median value being -$64.76 (2023).
- As far as peak fluctuations go, Mainz Biomed N.V's EPS (Weighted Average and Diluted) crashed by 4,498.52% in 2022, and later surged by 65.47% in 2024.
- Mainz Biomed N.V's EPS (Weighted Average and Diluted) (Yearly) stood at -$0.10 in 2020, then slumped by 1,448.88% to -$1.62 in 2021, then crashed by 4,498.52% to -$74.55 in 2022, then rose by 13.13% to -$64.76 in 2023, then surged by 65.47% to -$22.36 in 2024.